-
Abdel-Rahman MA, Quintero-Hernandez V, Possani LD, 2013: Venom proteomic and venomous glands transcriptomic analysis of the Egyptian scorpion Scorpio maurus palmatus (Arachnida: Scorpionidae)[J]. Toxicon, 74, 193-207. doi: 10.1016/j.toxicon.2013.08.064
-
Alesha Grant SS, Tripathi Shashank, Balasubramaniam Vinod, Lisa Miorin MS, Schwarz Megan C, SȢnchez-Seco Mari Paz, Matthew J, Evans SM, Garcáa-Sastre A, 2016: Zika virus impairs growth in human neurospheres and brain organoids[J]. Cell Host Microbe, 19, 882-890. doi: 10.1016/j.chom.2016.05.009
-
Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW, 2002: Toll-like receptor 4-dependent activation of dendritic cells by β-Denfensin 2[J]. Science, 298, 1025-1029. doi: 10.1126/science.1075565
-
Bogoch II, Brady OJ, Kraemer MU, German M, Creatore MI, Brent S, Watts AG, Hay SI, Kulkarni MA, Brownstein JS, Khan K, 2016: Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study[J]. Lancet Infect Dis, 16, 1237-1245. doi: 10.1016/S1473-3099(16)30270-5
-
Carballar-Lejarazu R, Rodriguez MH, Hernandez-Hernandez FC, Ramos-Castaneda J, Possani LD, Zurita-Ortega M, Reynaud-Garza E, Hernandez-Rivas R, Loukeris T, Lycett G, Lanz-Mendoza H, 2008: Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens[J]. Cell Mol Life Sci, 65, 3081-3092. doi: 10.1007/s00018-008-8250-8
-
Chan JF, Choi GK, 2016: Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease[J]. J Infect Dis, 220, 449-.
-
Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J, 2018: Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin[J]. Antivir Res, 155, 20-27. doi: 10.1016/j.antiviral.2018.04.018
-
Dai JF, Pan W, Wang PH, 2011: ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro[J]. Virol J, 8, 486-492. doi: 10.1186/1743-422X-8-486
-
Easton DM, Nijnik A, Mayer ML, Hancock RE, 2009: Potential of immunomodulatory host defense peptides as novel anti-infectives[J]. Trends Biotechnol, 27, 582-590. doi: 10.1016/j.tibtech.2009.07.004
-
Halstead SB, 2007: Dengue[J]. Lancet, 370, 1644-1652. doi: 10.1016/S0140-6736(07)61687-0
-
Hancock RE, Finlay BB, 2004: Can innate immunity be enhanced to treat microbial infections[J]. Nat Rev Microbiol, 2, 497-504. doi: 10.1038/nrmicro908
-
Heymann DL, Hodgson A, Sall AA, Freedman DO, Staples JE, Althabe F, Baruah K, Mahmud G, Kandun N, Vasconcelos FC, Bino S, Menon KU, 2016: Zika virus and microcephaly: why is this situation a PHEIC?[J]. Lancet, 387, 719-721. doi: 10.1016/S0140-6736(16)00320-2
-
Hilchie AL, Wuerth K, Hancock RE, 2013: Immune modulation by multifaceted cationic host defense (antimicrobial) peptides[J]. Nat Chem Biol, 9, 761-768. doi: 10.1038/nchembio.1393
-
Hishiki T, Han QE, Arimoto K, Shimotohno K, Igarashi T, Vasudevan SG, Suzuki Y, Yamamoto N, 2014: Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication[J]. Biochem Biophys Res Commun, 448, 95-100. doi: 10.1016/j.bbrc.2014.04.081
-
Holthausen DJ, Lee SH, Kumar VT, Bouvier NM, Krammer F, Ellebedy AH, Wrammert J, Lowen AC, George S, Pillai MR, Jacob J, 2017: An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses[J]. Immunity, 46, 587-595. doi: 10.1016/j.immuni.2017.03.018
-
Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z, 2013: Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus[J]. Biomaterials, 34, 3511-3522. doi: 10.1016/j.biomaterials.2013.01.075
-
Hong W, Li T, Song Y, Zhang R, Zeng Z, Han S, Zhang X, Wu Y, Li W, Cao Z, 2014: Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1[J]. Antivir Res, 102, 1-10.
-
Jiang SB, Lin K, Strick N, Neurath AR, 1993: HIV-1 inhibition by a peptide[J]. Nature, 365, 113-.
-
Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M, 2005: Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression[J]. J Virol, 79, 5414-5420. doi: 10.1128/JVI.79.9.5414-5420.2005
-
Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M, 2007: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide[J]. Nature, 449, 564-569. doi: 10.1038/nature06116
-
Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, Lin YL, 2009: Distinct antiviral roles for human 2¤, 5¤-oligoadenylate synthetase family members against dengue virus infection[J]. J Immunol, 183, 8035-8043. doi: 10.4049/jimmunol.0902728
-
Loo YM, Gale M Jr, 2011: Immune signaling by RIG-I-like receptors[J]. Immunity, 34, 680-692. doi: 10.1016/j.immuni.2011.05.003
-
McMichael AJ, Woodruff RE, Hales S, 2006: Climate change and human health: present and future risks[J]. Lancet, 367, 859-869. doi: 10.1016/S0140-6736(06)68079-3
-
Morrison J, Laurent-Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, Simon V, Mulder LC, Fernandez-Sesma A, Garcia-Sastre A, 2013: Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type Ⅰ interferon signaling[J]. PLoS Pathog, 9, e1003265-. doi: 10.1371/journal.ppat.1003265
-
Muller U, Steinhoff U, Reis LF, Hemmi S, Paviovic J, Zinkernagel RM, Aguet M, 1994: Functional role of type Ⅰ and type Ⅱ Interferons in antiviral defense[J]. Science, 264, 1918-1921. doi: 10.1126/science.8009221
-
Pichlmair A, Reis e Sousa C, 2007: Innate recognition of viruses[J]. Immunity, 27, 370-383. doi: 10.1016/j.immuni.2007.08.012
-
Reddy KV, Yedery RD, Aranha C, 2004: Antimicrobial peptides: premises and promises international[J]. J Antimicrob Agents, 24, 536-547. doi: 10.1016/j.ijantimicag.2004.09.005
-
Renaud Conde FZ, Rodriguez Mario H, Possani Lourival D, 2000: Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom[J]. FEBS Lett, 471, 165-168. doi: 10.1016/S0014-5793(00)01384-3
-
Sainz B, Halford WP, 2002: Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1[J]. J Virol, 76, 11541-11550. doi: 10.1128/JVI.76.22.11541-11550.2002
-
Schmidt AG, Yang PL, Harrison SC, 2010: Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate[J]. PLoS Pathog, 6, e1000851-. doi: 10.1371/journal.ppat.1000851
-
Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM, 2011: A diverse range of gene products are effectors of the type Ⅰ interferon antiviral response[J]. Nature, 472, 481-485. doi: 10.1038/nature09907
-
Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock RE, 2007: An anti-infective peptide that selectively modulates the innate immune response[J]. Nat Biotechnol, 25, 465-472. doi: 10.1038/nbt1288
-
Screaton G, Mongkolsapaya J, Yacoub S, Roberts C, 2015: New insights into the immunopathology and control of dengue virus infection[J]. Nat Rev Immunol, 15, 745-759. doi: 10.1038/nri3916
-
Seth RB, Sun L, Chen ZJ, 2006: Antiviral innate immunity pathways[J]. Cell Res, 16, 141-147. doi: 10.1038/sj.cr.7310019
-
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD, 2016: The global economic burden of dengue: a systematic analysis[J]. Lancet Infect Dis, 16, 935-941. doi: 10.1016/S1473-3099(16)00146-8
-
Theofilopoulos AN, Baccala R, Beutler B, Kono DH, 2005: Type Ⅰ interferons (alpha/beta) in immunity and autoimmunity[J]. Annu Rev Immunol, 23, 307-336. doi: 10.1146/annurev.immunol.23.021704.115843
-
Uawonggul N, Sukprasert S, Incamnoi P, Patramanon R, Thammasirirak S, Preecharram S, Bunyatratchata W, Kuaprasert B, Daduang J, Daduang S, 2014: Bacterial overexpression ofrecombinant heteroscorpine-1 (rHS-1), a toxin from Heterometrus laoticus scorpion venom: trends forantibacterial application and antivenom production[J]. Biochem Genet, 52, 459-473. doi: 10.1007/s10528-014-9660-y
-
Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J, 2008: Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever[J]. J Infect Dis, 197, 1459-1467. doi: 10.1086/589588
-
Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI, 2004: Lj Defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry[J]. J Virol, 78, 5147-5156. doi: 10.1128/JVI.78.10.5147-5156.2004
-
Yu JS, Tseng CK, Lin CK, Hsu YC, Wu YH, Hsieh CL, Lee JC, 2017a: Celastrol inhibits dengue virus replication via up-regulating type Ⅰ interferon and downstream interferon-stimulated responses[J]. Antivir Res, 137, 49-57. doi: 10.1016/j.antiviral.2016.11.010
-
Yu Y, Deng Y, Zou P, Wang Q, Dai Y, Yu F, Du L, Zhang N, Tian M, Hao J, Meng Y, Li Y, Zhou X, Chan JF, Yuen KY, Qin CF, Jiang SB, Lu L, 2017b: A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses[J]. Nat Commun, 8, 15672-. doi: 10.1038/ncomms15672
-
Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z, 2018: Histidine-rich modification of a scorpion-derived peptide improves bioavailability and inhibitory activity against HSV-1[J]. Theranostics, 8, 199-211. doi: 10.7150/thno.21425
-
Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian X, Li W, Cao Z, 2012: Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in vitro and in vivo[J]. J Biol Chem, 287, 30181-30190. doi: 10.1074/jbc.M112.370312